GSE159432
Transcriptional profiling of intestinal changes in Apc Kras tumours with MYC activation and/or drug combination treatment
Transcriptional profiling of intestinal changes in Apc Kras tumours with MYC activation and/or drug combination treatment Overall design: Apc Kras or Apc Kras MYC mice were treated with or without a eFT508/rapamycin drug combination, then whole intestines were extracted and transcriptomic analysis performed to investigate changes occuring with MYC and/or drug treatment.